YOLFTbeta
CSPC Innovation Pharmaceutical Co Ltd Class A

CSPC Innovation Pharmaceutical Co Ltd Class A

300765 · SHE · Consumer Defensive / Packaged Foods

34.36CNY-1.01 (-2.86%)

Price History

Full chart

Market Stats

Previous Close35.37
Open35.23
Day Range34.17 – 35.66
52-Week Range22.50 – 51.78
Volume9.48M
Market Cap66.28B
P/E (TTM)63.77
Forward P/E0.00
EPS0.74
Dividend Yield0.00%
Beta-0.01
50-Day Avg42.80
200-Day Avg35.36

About

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEODr. Bing Yao
  • Employees2.37K
  • HeadquartersNo. 62 Zhangju Road, Shijiazhuang, China, 051430, China
  • Websitehttps://www.xnwpharma.net

Leadership

  • Dr. Bing YaoExecutive Chairman · b. 1977
  • Mr. Long DaiGM, CFO & Director · b. 1992
  • Ms. Wen XuSecretary & Director · b. 1990
  • Dr. Xiwu HuiDeputy General Manager · b. 1986
  • Hong Chao LiHead of Accounting

Financials

Income Statement

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue650.72M742.01M890.48M1.03B1.24B1.26B1.32B1.85B2.63B2.54B1.98B2.15B
Growth (%)-+14.03%+20.01%+15.80%+20.26%+1.32%+4.85%+40.40%+42.00%-3.34%-21.98%+8.41%
Cost of Revenue398.05M458.67M470.73M528.38M632.81M613.27M584.91M1.04B1.49B1.38B1.16B1.46B
Gross Profit252.66M283.34M419.75M502.80M607.29M643.24M732.50M807.09M1.13B1.16B825.52M687.73M
Gross Margin38.83%38.19%47.14%48.76%48.97%51.19%55.60%43.63%43.15%45.51%41.68%32.03%
Operating Expense127.76M147.57M172.02M262.09M330.43M310.40M372.48M319.72M277.85M893.73M1.04B1.31B
Operating Income124.90M135.77M247.72M240.71M276.86M332.83M360.02M487.36M855.59M261.55M-218.34M-625.82M
Operating Margin19.19%18.30%27.82%23.34%22.33%26.49%27.33%26.35%32.58%10.30%-11.02%-29.14%
EBITDA148.18M162.20M278.48M277.49M324.34M384.04M419.06M550.43M924.67M417.53M1.76M-402.58M
EBITDA Margin22.77%21.86%31.27%26.91%26.15%30.56%31.81%29.76%35.21%16.45%0.09%-18.75%
Net Income108.24M115.59M206.58M194.91M223.84M273.20M299.84M393.23M726.28M434.44M53.73M-241.13M
Net Income Margin16.63%15.58%23.20%18.90%18.05%21.74%22.76%21.26%27.65%17.11%2.71%-11.23%
R&D26.79M26.51M9.53M8.51M11.25M13.05M14.05M26.50M46.30M671.40M842.20M931.06M
R&D as % of Total Revenue4.12%3.57%1.07%0.82%0.91%1.04%1.07%1.43%1.76%26.45%42.52%43.36%
Interest Expense--3.31M3.39M3.60M1.73M420.54K3.28M1.18M639.77K6.79M22.49M
Interest Expense % of Total Revenue--0.37%0.33%0.29%0.14%0.03%0.18%0.04%0.03%0.34%1.05%

Balance Sheet

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets831.82M957.02M968.68M1.13B1.39B2.85B2.96B3.74B4.58B7.47B6.02B6.28B
Total Liabilities294.66M330.20M396.66M362.16M391.45M437.06M269.65M443.58M639.84M1.99B1.53B3.48B
Total Equity537.16M624.93M572.02M766.93M990.77M2.41B2.68B3.29B3.94B5.28B3.73B2.67B
Cash133.79M181.27M150.59M68.22M156.39M475.14M1.14B1.24B2.20B3.77B872.08M772.17M
Total Debt-120.00M120.00M95.74M20.59M12.49M840.96K840.96K19.80M841.22K93.72M4.87M
Net Debt-133.79M-61.27M-150.59M27.51M-135.80M-475.14M-1.14B-1.24B-2.18B-3.77B-872.08M-767.30M

Cash Flow

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow93.36M112.05M137.27M1.30M159.73M315.38M349.07M292.09M640.72M927.24M-1.24B-195.69M
Investing Cash Flow-26.08M-84.69M20.39M-46.72M-45.99M-1.07B346.17M-155.36M311.88M-92.99M-1.29B-418.51M
Financing Cash Flow-6.00M19.34M-191.94M-35.22M-28.23M1.07B-28.00M-42.86M-63.01M365.21M-392.51M504.19M
Capital Expenditure8.09M47.67M147.79M42.78M58.96M106.10M117.74M66.92M114.05M95.73M477.78M568.39M
Free Cash Flow85.28M64.38M-10.52M-41.48M100.76M209.28M231.33M103.67M526.67M831.51M-1.71B-764.08M
Dividends Paid-1.75M53.24M24.84M3.39M1.50M28.00M42.00M82.07M97.85M374.16M36.43M
FCF to OCF91.34%57.46%-7.67%-3190.39%63.09%66.36%66.27%35.49%82.20%89.68%138.68%390.45%
Dividend Paid to FCF-2.72%-505.88%-59.88%3.37%0.72%12.10%40.51%15.58%11.77%-21.84%-4.77%

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 4, 2021Apr 26, 2021Aug 20, 2021Oct 22, 2021Mar 4, 2022Apr 28, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Aug 18, 2023Oct 24, 2023Mar 14, 2024May 15, 2024Aug 17, 2024Oct 23, 2024Mar 21, 2025Apr 23, 2025Aug 16, 2025Oct 29, 2025Mar 18, 2026Apr 29, 2026Aug 18, 2026
EPS Estimate------------------------------
EPS Actual0.050.070.060.050.060.090.070.080.150.150.150.130.200.160.140.200.130.190.160.150.070.040.00-0.06-0.020.02-0.02-0.16-0.070.97
Surprise------------------------------
Timing-----------Pre-marketPre-market----Pre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap66.28B
Enterprise Value63.22B
Trailing P/E63.77
Forward P/E0.00
Price / Sales15.24
Price / Book16.82
EPS0.74
Book Value2.83
Revenue (TTM)4.35B
Gross Profit (TTM)2.90B
EBITDA1.37B
Profit Margin23.52%
Operating Margin65.79%
Return on Equity26.10%
Return on Assets9.51%
Shares Outstanding1.40B
Shares Float343.94M
Beta-0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.02May 29, 2025
20241×
0.32Apr 25, 2024
20231×
0.13Apr 27, 2023
20221×
0.07Jun 7, 2022
20211×
0.04Apr 28, 2021
20201×
0.02Apr 29, 2020

Stock Splits

  • Apr 25, 20241.2:1
  • Apr 27, 20231.8:1
  • Apr 28, 20211.3:1
  • Apr 29, 20202.1:1